Patent ID: 8552253
Filing Date: 2013-10-08
Classification: A01K

Abstract:
1. A screening method of a drug for protection or treatment of attention deficit hyperactivity disorder (ADHD), comprising: (1) administering a candidate material of the drug for protection or treatment of attention deficit hyperactivity disorder (ADHD) to a homozygous GIT1 knock-out mouse; (2) after administration of the candidate material in operation (1), conducting an attention deficit hyperactivity disorder (ADHD) test of the mouse, wherein the ADHD test is at least one selected from Open field test, Home-cage activity test, Morris water maze test, Novel object recognition test, and Electroencephalogram; and (3) selecting the candidate material by which the attention deficit hyperactivity disorder (ADHD) is reduced as compared to a control group without administering the candidate material.